)
Visual
test
Pharma Equity Group
Pharma Equity Group (PEG) investor relations material
Pharma Equity Group Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary25 Mar, 2026
Executive summary
Net loss narrowed to DKK -25.4m in 2025 from DKK -40.6m in 2024, reflecting reduced development spend and cost discipline.
Regulatory approval obtained to initiate Phase 2 study for RNX-011; advanced partner discussions ongoing for RNX-051.
New investment strategy launched to diversify the portfolio; continued efforts to recover Portinho receivables.
Financial highlights
Cash and cash equivalents at year-end were DKK 0.5m, down from DKK 4.2m in 2024.
Total assets decreased to DKK 38.9m from DKK 49.4m year-over-year.
Equity at year-end was DKK 25.5m, including DKK 18.2m in convertible instruments.
Subordinated convertible debt reduced to DKK 4.2m from DKK 8.1m.
Allowance for Portinho receivable was DKK -8.1m, down from DKK -16.2m in 2024.
Outlook and guidance
2026 revenue guidance: DKK 3.0–8.6m; EBIT guidance: DKK -5.8m to -11.3m.
Key 2026 drivers include first patient enrollment in RNX-011 and RNX-051 trials, signing first license agreement for RNX-051, and strengthening financial position.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharma Equity Group
- First partnership targeted for 2025, led by an experienced director and global network expansion.PEG
Investor Update1 Feb 2026 - H1 loss of DKK 13m, clinical progress, and capital raise plans amid receivable recovery efforts.PEGQ2 202424 Jan 2026
- Capital raise strengthens balance sheet, reduces debt, and targets licensing deal by 2025.PEGInvestor Update19 Jan 2026
- Received approval to start pivotal Phase 2 trial for RNX-011 in life-threatening peritonitis.PEGInvestor Update10 Sep 2025
- Net loss improved, no revenue yet, and Portinho S.A. receivable remains a key focus.PEGQ2 202514 Aug 2025
- Losses in line with expectations, capital strengthened, and key patent secured in Japan.PEGQ3 202413 Jun 2025
- 2024 loss in line with expectations; capital strengthened, first revenue expected late 2025.PEGQ4 20249 Jun 2025
Next Pharma Equity Group earnings date
Q2 202614 Aug, 2026
Pharma Equity Group
Next Pharma Equity Group earnings date
Q2 202614 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage